期刊文献+
共找到7篇文章
< 1 >
每页显示 20 50 100
心管通治疗冠心病心绞痛的临床观察
1
作者 段明勤 吴淑伦 +1 位作者 张翠萍 赵延甫 《临床医学》 CAS 2000年第12期40-41,共2页
心血通注射液的主要成分降钙素基因相关肽是目前发现的最强的扩血管物质之一,对心血管系统有着重要的调节作用,能明显改善心肌缺血再灌注损伤。我们在60例患者中对静脉滴注心血通治疗冠心病心绞痛的疗效进行临床观察,报告如下:
关键词 冠心病 心绞痛 静脉滴注 心管通 扩血管药
原文传递
Wnt/β-catenin Signaling Cascades in Cardiovascular Diseases
2
作者 QI Yan-Fei LIU Yan-Ping +1 位作者 XU Wen-Qing YAN Xiao-Xue 《生物化学与生物物理进展》 SCIE CAS CSCD 北大核心 2024年第10期2328-2339,共12页
Cardiovascular diseases are a group of disorders of the heart and blood vessels,primarily including coronary heart disease,stroke,and other diseases.It is the world’s leading cause of death,and its incidence is incre... Cardiovascular diseases are a group of disorders of the heart and blood vessels,primarily including coronary heart disease,stroke,and other diseases.It is the world’s leading cause of death,and its incidence is increasing yearly.Hypertension is a major risk factor for cardiovascular disease.Wnt signaling comprises a series of highly conservative cascading events controlling fundamental biological processes.Wnt signaling pathways include the canonical Wnt pathway(or Wnt/β-catenin pathway),the non canonical planar cell-polarity pathway,and the non-canonical calcium-dependent pathways.Abnormal Wnt signaling promotes cell proliferation and differentiation,cardiac malformations,various malignancies,so drugs targeting Wnt signaling play a great therapeutic potential.Wnt/β-catenin pathway is involved in the occurrence and development of cardiovascular diseases such as atherosclerosis and stroke by regulating cell proliferation,migration,apoptosis,blood-brain barrier permeability,inflammation,oxidative stress,and immune response.Based on the latest research progress,this review summarizes the role of Wnt/β-catenin signaling in cardiovascular diseases,in order to provide new ideas for the prevention and treatment of cardiovascular diseases. 展开更多
关键词 Wnt/β-catenin pathway cardiovascular diseases pathological process
下载PDF
A retrospective observational study on maintenance and complications of totally implantable venous access ports in 563 patients:Prolonged versus short flushing intervals 被引量:7
3
作者 Yuejiao Zhang Ruiyi Zhao +3 位作者 Nan Jiang Yun Shi Qianmi Wang Ye Sheng 《International Journal of Nursing Sciences》 CSCD 2021年第3期252-256,I0001,共6页
Objectives:To assess whether the extension of the flushing interval will increase risks of complications associated with totally implantable venous access port(TIVAP)in the off-treatment period.Methods:A retrospective... Objectives:To assess whether the extension of the flushing interval will increase risks of complications associated with totally implantable venous access port(TIVAP)in the off-treatment period.Methods:A retrospective single-center observational study was performed.Patients with a TIVAP in the off-treatment period that underwent regular flushing in our clinic were included.Data concerning patients and their TIVAPs were recorded.Patient baseline characteristics and TIVAP-related complications were analyzed.Continuous variables were analyzed by ANOVA or the Kruskal-Wallis H test.To compare the occurrence of TIVAP-related complications,the chi-square test was used;if needed,Fisher’s exact test was used.Results:Totally 607 patients were reviewed,and 563 patients were finally included.Thirteen complications were recorded,including 11 cases of catheter occlusion(1.95%),one case of port cannula rotation(0.18%),and one case of catheter tip malposition(0.18%).No device-related infection or venous thrombosis was recorded.Among these patients,the average flushing interval was 35.27±13.09 days.Patients were divided into three groups according to the flushing interval:every 28 days or less(Group 1,n=133);every 29-44 days(Group 2,n=350);and every 45 days or more(Group 3,n=80).No significant difference in catheter-related complications was found among the three groups(P>0.05).Conclusions:In the TIVAP off-treatment period,patients without any history of TIVAP-related complications during approximately one year can attempt to prolong the flushing interval to more than 4 weeks;we further suggest that 5-6 weeks may be an appropriate option for these patients. 展开更多
关键词 Central venous access devices COMPLICATIONS Flushing interval OUTPATIENTS
下载PDF
Curative Effect of Naoxintong Capsule in Treating Senile Cerebral Arteriosclerosis
4
作者 林坚 王珏 《Journal of Zhejiang University-Science B(Biomedicine & Biotechnology)》 SCIE CAS CSCD 2008年第9期532-533,共2页
Objective: To observe the curative effect of Naoxintong capsule in treating senile cerebral arteriosclerosis. Methods:60 cases of senile cerebral arteriosclerosis were randomly divided into the contrast group and th... Objective: To observe the curative effect of Naoxintong capsule in treating senile cerebral arteriosclerosis. Methods:60 cases of senile cerebral arteriosclerosis were randomly divided into the contrast group and the treatment group with 30 cases each group. Same medicine was used in two groups. The treatment group was added with Naoxintong capsule. The cerebrovascular hemodynamics index (CVDI) of fight carotid was compared before and after therapy. Results: CVDI of the treatment group after therapy was significantly different from that before therapy ( P 〈 0.05 ~ 0.01 ). Conclusion: Naoxintong capsule has certain curative effect in treating senile cerebral arteriosclerosis. 展开更多
关键词 cerebral arteriosclerosis Naoxintong capsule CVDI
下载PDF
Recombinant adeno-associated virus serotype 9 with p65 ribozyme protects H9c2 cells from oxidative stress through inhibiting NF-κB signaling pathway 被引量:5
5
作者 Zhan SUN Yi-Tong MA +1 位作者 Bang-Dang CHEN Fen LIU 《Journal of Geriatric Cardiology》 SCIE CAS CSCD 2014年第4期311-315,共5页
Background Oxidative stress is a major mechanism underlying the pathogenesis of cardiovascular disease. It can trigger inflammatory cascades which are primarily mediated via nuclear factor-κB (NF-κB). The NF-κB t... Background Oxidative stress is a major mechanism underlying the pathogenesis of cardiovascular disease. It can trigger inflammatory cascades which are primarily mediated via nuclear factor-κB (NF-κB). The NF-κB transcription factor family includes several subunits (p50, p52, p65, c-Rel, and Rel B) that respond to myocardial ischemia. It has been proved that persistent myocyte NF-κB p65 activation in heart failure exacerbates cardiac remodeling. Mechods A recombinant adeno-associated virus serotype 9 carrying enhanced green fluorescent protein and anti-NF-κB p65 ribozyme (AAV9-R65-CMV-eGFP) was constructed. The cells were assessed by MTT assay, Annexin V–propidium iodide dual staining to study apoptosis. The expression of P65 and P50 were assessed by Western blot to investigate the under-lying molecular mechanisms. Results After stimulation with H2O2 for 6 h, H9c2 cells viability decreased significantly, a large fraction of cells underwent apoptosis. We observed a rescue of H9c2 cells from H2O2-induced apoptosis in pretreatment with AAV9-R65-CMV-eGFP. Moreover, AAV9-R65-CMV-eGFP decreased H2O2-induced P65 expression. Conclusions AAV9-R65-CMV-eGFP protects H9c2 cells from oxidative stress induced apoptosis through down-regulation of P65 expression. These observations indicate that AAV9-R65-CMV-eGFP has the potential to exert cardioprotective effects against oxidative stress, which might be of great importance to clinical efficacy for cardiovascular disease. 展开更多
关键词 CARDIOMYOCYTES ADENOVIRUS R65 ribozyme Apoptosis NF-κB pathway
下载PDF
Hypertension in the elderly: insights from recent research
6
作者 Jun-Hua Wang Shan Zhou 《Journal of Geriatric Cardiology》 SCIE CAS CSCD 2010年第2期116-125,共10页
Hypertension is a leading cause of mortality and morbidity around the world and,prevalence of hypertension is increasing with aging.Hypertension in the elderly is associated with increased occurrence rates of sodium s... Hypertension is a leading cause of mortality and morbidity around the world and,prevalence of hypertension is increasing with aging.Hypertension in the elderly is associated with increased occurrence rates of sodium sensitivity,isolated systolic hypertension,and 'white coat effect'.Arterial stiffness and endothelial dysfunction also increase with age.These factors should be considered in selecting antihypertensive therapy.The prime objective of this therapy is to prevent stroke.The fmdings of controlled trials show that there should be no cut-off age for treatment.A holistic program for controlling cardiovascular risks should be fully discussed with the patient,including evaluation to exclude underlying causes of secondary hypertension,and implementation of lifestyle measures.The choice of antihypertensive drug therapy is influenced by concomitant disease and previous medication history,but will typically include a thiazide diuretic as the first-line agent;to this will be added an angiotensin inhibitor and/or a calcium channel blocker.Beta blockers are not generally recommended,in part because they do not combat the effects of increased arterial stiffness.The hypertension-hypoten-sion syndrome requires case-specific management.Drug-resistant hypertension is important to differentiate from faulty compliance with medication.Patients resistant to the third-line drug therapy may benefit from treatment with extended-release isosorbide mononitrate.A trial of spironolactone may also be worthwhile. 展开更多
关键词 HYPERTENSION ELDERLY antihypertensive treatment patient management
下载PDF
Ca^(2+) signalling in cardiovascular disease:the role of the plasma membrane calcium pumps 被引量:12
7
作者 Elizabeth J.CARTWRIGHT Delvac OCEANDY +1 位作者 Clare AUSTIN Ludwig NEYSES 《Science China(Life Sciences)》 SCIE CAS 2011年第8期691-698,共8页
The plasma membrane calcium ATPases(PMCA) are a family of genes which extrude Ca2+from the cell and are involved in the maintenance of intracellular free calcium levels and/or with Ca2+signalling,depending on the cell... The plasma membrane calcium ATPases(PMCA) are a family of genes which extrude Ca2+from the cell and are involved in the maintenance of intracellular free calcium levels and/or with Ca2+signalling,depending on the cell type.In the cardiovascular system,Ca2+ is not only essential for contraction and relaxation but also has a vital role as a second messenger in signal transduction pathways.A complex array of mechanisms regulate intracellular free calcium levels in the heart and vasculature and a failure in these systems to maintain normal Ca2+homeostasis has been linked to both heart failure and hypertension.This article focuses on the functions of PMCA,in particular isoform 4(PMCA4) ,in the heart and vasculature and the reported links between PMCAs and contractile function,cardiac hypertrophy,cardiac rhythm and sudden cardiac death,and blood pressure control and hypertension.It is becoming clear that this family of calcium extrusion pumps have essential roles in both cardiovascular health and disease. 展开更多
关键词 plasma membrane calcium/calmodulin-dependent ATPase Ca2+ homeostasis Ca2+ signalling heart failure hypertension
原文传递
上一页 1 下一页 到第
使用帮助 返回顶部